Cargando…

Adaptive immune responses to SARS-CoV-2()

This review focuses on adaptive immune responses against SARS-CoV-2, the coronavirus that causes COVID-19. A great deal of work has been accomplished in a very short period of time to describe adaptive immune responses and to ascertain their roles in determining the course of infection. As with othe...

Descripción completa

Detalles Bibliográficos
Autor principal: Forthal, Donald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891074/
https://www.ncbi.nlm.nih.gov/pubmed/33610693
http://dx.doi.org/10.1016/j.addr.2021.02.009
_version_ 1783652629191065600
author Forthal, Donald
author_facet Forthal, Donald
author_sort Forthal, Donald
collection PubMed
description This review focuses on adaptive immune responses against SARS-CoV-2, the coronavirus that causes COVID-19. A great deal of work has been accomplished in a very short period of time to describe adaptive immune responses and to ascertain their roles in determining the course of infection. As with other viral infections, SARS-CoV-2 elicits both antibody and T-cell responses. Whereas antibody responses are likely effective in preventing infection and may participate in controlling infection once established, it is less clear whether or not they play a role in pathogenesis. T cells are likely involved in controlling established infection, but a pathogenic role is also possible. Longer term evaluation is necessary to determine the durability of protective immune responses.
format Online
Article
Text
id pubmed-7891074
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-78910742021-02-19 Adaptive immune responses to SARS-CoV-2() Forthal, Donald Adv Drug Deliv Rev Article This review focuses on adaptive immune responses against SARS-CoV-2, the coronavirus that causes COVID-19. A great deal of work has been accomplished in a very short period of time to describe adaptive immune responses and to ascertain their roles in determining the course of infection. As with other viral infections, SARS-CoV-2 elicits both antibody and T-cell responses. Whereas antibody responses are likely effective in preventing infection and may participate in controlling infection once established, it is less clear whether or not they play a role in pathogenesis. T cells are likely involved in controlling established infection, but a pathogenic role is also possible. Longer term evaluation is necessary to determine the durability of protective immune responses. Elsevier B.V. 2021-05 2021-02-18 /pmc/articles/PMC7891074/ /pubmed/33610693 http://dx.doi.org/10.1016/j.addr.2021.02.009 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Forthal, Donald
Adaptive immune responses to SARS-CoV-2()
title Adaptive immune responses to SARS-CoV-2()
title_full Adaptive immune responses to SARS-CoV-2()
title_fullStr Adaptive immune responses to SARS-CoV-2()
title_full_unstemmed Adaptive immune responses to SARS-CoV-2()
title_short Adaptive immune responses to SARS-CoV-2()
title_sort adaptive immune responses to sars-cov-2()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891074/
https://www.ncbi.nlm.nih.gov/pubmed/33610693
http://dx.doi.org/10.1016/j.addr.2021.02.009
work_keys_str_mv AT forthaldonald adaptiveimmuneresponsestosarscov2